- JUST THE NEWS - Greg Piper - JAN 10, 2022 -
COVID-diabetes study would "never pass peer review in this form," said former Harvard Med School dean. "CDC must do better."
Even as CDC Director Rochelle Walensky has started sounding more like COVID-19 policy skeptics, the agency continues promoting research that fits its agenda but quickly provokes professional challenge.
For the second time in less than a month, medical experts pounced on the methodology of a study published in the agency's Morbidity and Mortality Weekly Report, which is not peer-reviewed.
The CDC's COVID and diabetes researchers found that children and teens who recovered from infections are "up to" 2.5 times likelier to develop diabetes, which was uncritically reported across mainstream media Friday.
The increased risk to this age group shows the importance of COVID prevention, "including vaccination for all eligible persons," researchers wrote. "Prevent COVID-19 by using tools like masks and #vaccines for those eligible," the agency tweeted.
Medical professors at the University of Pittsburgh, University of California San Francisco and Harvard's medical and public health schools quickly provided informal — and highly critical — peer review.
The study has "really really major limitations," according to Walid Gellad, director of Pitt's Center for Pharmaceutical Policy & Prescribing, citing its own disclosures.
LEIA MAIS >
Acesse a minha HOME PAGE, para assistir meus vídeos e ler meus livros: https://www.heitordepaola.online/